CDK4 and CDK6 variants in patients with primary microcephaly lead to cell cycle defects and mitochondria-induced

Esra Isik1, Mohammad Faraz Zafeer2, Guney Bademci3

  • 1Pediatric Genetics, Ege University, Izmir, Turkey.

Abstract

Insights

Loss-of-function variants in CDK4 and CDK6 disrupt neural progenitor proliferation, causing mitochondrial stress and apoptosis. This research links cell cycle regulation to mitochondrial health in neurodevelopmental disorders.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Neural progenitor proliferation is crucial for brain development, and its disruption causes microcephaly.
  • The roles of cyclin-dependent kinases 4 (CDK4) and 6 (CDK6) in neurodevelopmental stress responses are not fully understood.

Purpose of the Study:

  • To investigate the impact of CDK4 and CDK6 loss-of-function variants on neural progenitor cells.
  • To elucidate the cellular mechanisms linking cell cycle arrest to progenitor loss and brain growth disorders.

Main Methods:

  • Studied fibroblasts from individuals with microcephaly carrying pathogenic variants in CDK4 or CDK6.
  • Assessed DNA synthesis, cell cycle progression, mitochondrial activity, reactive oxygen species (ROS) production, and apoptosis in mutant fibroblasts.

Main Results:

  • Loss-of-function variants in CDK4 and CDK6 impaired fibroblast proliferation and DNA synthesis.
  • Mutant cells showed increased mitochondrial stress, ROS production, and apoptosis, with distinct mitochondrial responses to CDK4 versus CDK6 deficiency.
  • Both variants disrupted mTOR pathway signaling, connecting cell cycle kinase dysfunction to metabolic dysregulation.

Conclusions:

  • CDK4/CDK6 dysfunction triggers a mitochondrial stress response, contributing to neural progenitor depletion and microcephaly.
  • These findings highlight a link between cell cycle regulation, mitochondrial homeostasis, and neurodevelopment, with implications for neurodegeneration and cancer research.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

3.0K